Cargando…

Apomorphine

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	1888
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473977/ https://www.ncbi.nlm.nih.gov/pubmed/36668261

Ejemplares similares

Apomorphine
Publicado: (1900)

Apomorphine effects on the hippocampus
por: Arroyo-García, Luis Enrique, et al.
Publicado: (2018)

On the Anæsthetic Action of Apomorphine
Publicado: (1885)

Some Observations on the Use of Apomorphine
por: Horsley, J. S.
Publicado: (1912)

Is Apomorphine a Safe Emetic?
por: Brown, John
Publicado: (1889)

Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
por: Hagell, Peter, et al.
Publicado: (2020)

Population pharmacokinetic analysis of apomorphine sublingual film or subcutaneous apomorphine in healthy subjects and patients with Parkinson’s disease
por: Agbo, Felix, et al.
Publicado: (2021)

Apomorphine Hydrochloride in the Treatment of Persistent Hiccough
por: Panda, R. C.
Publicado: (1928)

The Pharmacological Properties and Therapeutic Use of Apomorphine
por: Ribarič, Samo
Publicado: (2012)

Apomorphine in Parkinson's Disease—The Questions Raised
por: Dhamija, Rajinder K., et al.
Publicado: (2020)

Looking Beyond the Fog—Apomorphine Demystified
por: LK, Prashanth, et al.
Publicado: (2020)

Necrotic Ulcers Secondary to Apomorphine Infusion
por: Llamas-Osorio, Yudy, et al.
Publicado: (2021)

A Case of Hiccough Cured with Apomorphine Hydrochloride
por: Dutt, K. N.
Publicado: (1933)

Apomorphine Targets the Pleiotropic Bacterial Regulator Hfq
por: Turbant, Florian, et al.
Publicado: (2021)

Effect of apomorphine on cognitive performance and sensorimotor gating in humans
por: Schellekens, Arnt F. A., et al.
Publicado: (2009)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
por: Antonini, Angelo
Publicado: (2009)

Au nanoparticle-based sensor for apomorphine detection in plasma
por: Zanchi, Chiara, et al.
Publicado: (2015)

Stability of apomorphine in solutions containing selected antioxidant agents
por: Ang, Zen Yang, et al.
Publicado: (2016)

Task Specific Tremor in Parkinson’s Disease Responds to Apomorphine
por: Ondo, William G., et al.
Publicado: (2023)

Night‐Time Apomorphine Infusion: Who Are the Best Candidates?
por: Cochen De Cock, Valérie, et al.
Publicado: (2023)

Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option?
por: Desjardins, Clément, et al.
Publicado: (2023)

Relationship of Dopamine of the Nucleus Accumbens with Intra-infralimbic Apomorphine Microinjection
por: Alimoradian, Abbas, et al.
Publicado: (2013)

Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease
por: Isaacson, Stuart, et al.
Publicado: (2016)

Investigation into the Action of Apomorphin as an Emetic in Its Physiological and Therapeutic Relations
por: Riegel, Franz, et al.
Publicado: (1872)

The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future
por: Auffret, Manon, et al.
Publicado: (2018)

Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
por: Carbone, Federico, et al.
Publicado: (2019)

Apomorphine: The Initial Indian Experience in Relation to Response Tests and Pumps
por: Prashanth, LK, et al.
Publicado: (2020)

Investigation of apomorphine during sleep in Parkinson’s: Improvement in UPDRS Scores
por: Pieroni, Miguel A.
Publicado: (2019)

Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging
por: Wen, Chih-Jen, et al.
Publicado: (2012)

Turmeric active substance, curcumin, enhanced apomorphine-induced yawning in rats
por: Tamaddonfard, Esmaeal
Publicado: (2013)

Dopamine-transporter levels drive striatal responses to apomorphine in Parkinson's disease
por: Passamonti, Luca, et al.
Publicado: (2013)

Correction to: The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future
por: Auffret, Manon, et al.
Publicado: (2018)

Validations of apomorphine-induced BOLD activation correlations in hemiparkinsonian rhesus macaques
por: Quintero, J.E., et al.
Publicado: (2019)

Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease
por: Borkar, Nrupa, et al.
Publicado: (2018)

Inhibitory Effect of Apomorphine on Focal and Nonfocal Plasticity in the Human Motor Cortex
por: Fresnoza, Shane M., et al.
Publicado: (2021)

Systematic Review of the Apomorphine Challenge Test in the Assessment of Dopaminergic Activity in Schizophrenia
por: Duval, Fabrice
Publicado: (2023)

A Pig Model to Assess Skin Lesions after Apomorphine Application
por: Martin, Vera, et al.
Publicado: (2023)

Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease
por: Jenner, P., et al.
Publicado: (2023)

Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label Study
por: Agbo, Felix, et al.
Publicado: (2021)

Continuous Subcutaneous Apomorphine Infusion in Advanced Parkinson’s Disease: A Systematic Review
por: Gaire, Suman, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_no209n6cdj7tbhsi51em67t2mq